Andrew D.C. LaFrence

CIK 1850633 · CHIEF FINANCIAL OFFICER · last filed 2026-06-12

Andrew D.C. LaFrence is a CHIEF FINANCIAL OFFICER who has filed 10 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for SKYT, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$29.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $490.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$490.5K

Companies

4

Total Filings

10

Lifetime Open-Market Net

$29.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SKYT Director 15,732 $31.18 $490.5K $0 2 2026-06-12
NSYS CHIEF FINANCIAL OFFICER $14.46 $0 1 2023-12-05
KRMD Chief Financial Officer $4.01 $0 1 2023-07-18
Vyant Bio, Inc. (VYNT) Delisted Chief Financial Officer 12,823 $0.19 $2.5K $29.8K 6 2022-03-17

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 SKYT Grant (A) +4,304 $0 EDGAR
2025-05-23 SKYT Grant (A) +11,428 $100.0K EDGAR
2023-12-05 NSYS Grant (A) $0 EDGAR
2023-07-18 KRMD Grant (A) $0 EDGAR
2022-03-17 Vyant Bio, Inc. (VYNT) Delisted Grant (A) $0 EDGAR
2021-12-29 Vyant Bio, Inc. (VYNT) Delisted Buy (P) +5,000 $10.0K EDGAR
2021-11-24 Vyant Bio, Inc. (VYNT) Delisted Buy (P) +5,000 $10.0K EDGAR
2021-07-13 Vyant Bio, Inc. (VYNT) Delisted Other (J) +56,117 $0 EDGAR
2021-05-21 Vyant Bio, Inc. (VYNT) Delisted Buy (P) +3,000 $9.8K EDGAR
2021-04-01 Vyant Bio, Inc. (VYNT) Delisted Mixed +56,202 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.